Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

October 15, 2020

Study Completion Date

November 1, 2020

Conditions

COVID-19Desaturation of Blood

Interventions

DEVICE

Hyperbaric oxygen therapy

8 sessions in 4 days of breathing 100% oxygen in 2.2 ATA. Each session is 60 minutes. 1 meter/minute compression/decompression

Trial Locations (1)

Amir Hadanny, Ẕerifin

All Listed Sponsors

lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT04358926 - Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) | Biotech Hunter | Biotech Hunter